Keystone Symposia
Home | My Account | Shopping Cart  0
  Advanced
   Meetings AboutUs Donors Students Resources Contact My AccountCommunity
Please note: All programs are subject to change. Check this site for updates.

This meeting is part of the Global Health Series

Continuing Medical Education (CME) credits are available.



View similar meetings on...
Infectious Diseases

LANGUAGE NOTE: This meeting will be conducted in English.


Students and Post-Doctoral Trainees in Thailand... Click here for information about applying for a registration subsidy.


Register YourselfRegister a ColleagueSubmit an AbstractSubmit Colleague's Abstract


Meeting Program

To view program in "24 hour" time (international) click here.


Wednesday, October 22
2:00 - 6:00 PM Registration
6:00 - 7:00 PM Transportation to Dinner Event
7:00 - 9:00 PM Joint Dinner with Grand Challenges in Global Health Conference


NOTE: Dress code for the October 22nd dinner will apply for all participants: for men, business pants and open neck shirt is fine. For ladies, a smart dress is perfect.
Thursday, October 23
7:00 - 8:00 AM Breakfast
7:00 - 8:00 AM Poster Setup
8:00 - 11:30 AM Infection Biology
Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008
Craig R. Roy, Yale University School of Medicine
Modulation of Host Cell Functions by Type IV Effector Proteins
Dana Philpott, University of Toronto
Nod-Like Receptors
Jean-Laurent Casanova, INSERM U 550 Faculté de Médecine Necker
Genetic Susceptibility to Infectious Diseases
Arturo Zychlinsky, Max Plank Institute for Infection Biology
Neutrophil Extracellular Traps
9:20 - 9:40 AM Coffee Break
11:30 AM- 12:30 PM Lunch
12:00 - 2:00 PM Poster Session 1
Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008
2:00 - 4:00 PM HIV Drug Resistance
Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008
Robert F. Siliciano†, Johns Hopkins School of Medicine
Reservoirs and the Problem of Virus Eradication in Patients
Edward V. Arnold, Rutgers University
RT Structure and Structure-Guided Design of Novel Inhibitors Targeting Multiple Sites
Stephen Hughes, NCI-Frederick, NIH
HIV-1 RT Drug Resistance and Drug Development
4:00 - 4:30 PM Coffee Break
4:30 - 6:30 PM Workshop 1: TB
Clifton E. Barry III, NIAID, National Institutes of Health
Short Talks to be Chosen from Abstracts,
Friday, October 24
7:00 - 8:00 AM Breakfast
7:00 - 8:00 AM Poster Setup
8:00 - 11:30 AM Malaria
Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008
Robert Ménard, Institut Pasteur
In vivo Imaging of Plasmodium Pre-erythrocytic Stages in a Rodent Model
Louis Schofield, Walter and Eliza Hall Institute of Medical Research
Malaria and Vaccines
Daniel E. Goldberg, Washington University
Characterization of a Potential Drug Target: Plasmodium Calpain
Alan Cowman, Walter and Eliza Hall Institute of Medical Research
Invasion and Remodeling of the Human Erythrocyte by the Malaria Parasite
Sumalee Kamchonwongpaisan, BIOTEC, Thailand National Science and Technology Development Agency
Basic Understanding of Artemisinin Action against Plasmodium falciparum In Vitro
Yongyuth Yuthavong, BIOTEC, Thailand National Science and Technology Development Agency
Development of Target-Based Antimalarials
9:20 - 9:40 AM Coffee Break
11:30 AM- 12:30 PM Lunch
12:00 - 2:00 PM Poster Session 2
Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008
2:00 - 5:00 PM Diarrhea and Vaccines
Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008
E. Peter Greenberg, University of Washington
WHAT'S NEW IN ACYL-HOMOSERINE LACTONE QUORUM SENSING: STRANGE SIGNALS AND STRANGE RECEPTORS
Julian Guttman, Simon Fraser University
Epithelial Cell Alterations that Influence Diarrhea Generation During Attaching and Effacing Bacterial Infections
Philippe J. Sansonetti, Institut Pasteur
Shigella : a tool box to tinker with the host immune response.
John J. Mekalanos, Harvard Medical School
Cholera
3:20 - 3:40 PM Coffee Break
Saturday, October 25
7:00 - 8:00 AM Breakfast
7:00 - 8:00 AM Poster Setup
8:00 - 11:30 AM TB (and XDR)
Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008
Megan Murray, Harvard School of Public Health
Title to be Determined
Nacer Lounis, Tibotec
Diarylquinolines Have the Potential to Shorten TB Treatment Duration
William R. Jacobs, Jr., Albert Einstein College of Medicine
IKEPLUS, A Recombinant M. smegmatis that Elicits Bacteriocidal Immunity against Virulent M. tuberculosis
Valerie Mizrahi, University of the Witwatersrand - MMRU
Environment-Dependent Mutators and their Role in the Evolution of Drug Resistance in Mycobacterium tuberculosis
Douglas B. Young, Imperial College London
TB Drugs
9:20 - 9:40 AM Coffee Break
11:30 AM- 12:30 PM Lunch
12:00 - 2:00 PM Poster Session 3
Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008
2:00 - 5:00 PM Respiratory Pathogens
Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008
Maria Rescigno, European Institute of Oncology
Handling of Bacteria by Dendritic Cells at Mucosal Surfaces
Birgitta Henriques-Normark, Karolinska Institutet
The role of pneumococcal pili in Carriage and in Invasive Disease
Scott D. Gray-Owen, University of Toronto
The Pathogenic Neisseria: Dancing with Humans
Jeremy Farrar, Oxford University Clinical Research Unit - Hospital for Tropical Diseases
Globalization and Infectious Diseases: A Threat and an Opportunity for Collaborative Clinical Science
Joseph DeRisi†, University of California, San Francisco
Title to be Determined
3:20 - 3:40 PM Coffee Break
5:30 - 7:30 PM Workshop 2: Malaria
Brendan S. Crabb, Burnet Institute
Short Talks to be Chosen from Abstracts,
Sunday, October 26
7:00 - 8:00 AM Breakfast
8:00 - 11:30 AM Vaccines
Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008
Gordon Dougan, Wellcome Trust Sanger Institute
Vaccines against Invasive Salmonellosis
Cecil Czerkinsky, International Vaccine Institute
Mucosal Immunity and Vaccine Development
Rino Rappuoli, Novartis Vaccines & Diagnostics
Meringo coccus and Neglected Diseases
Adrian V.S. Hill, Jenner Institute, Oxford University
Vectored Vaccines against Intracellular Pathogens
Stefan H.E. Kaufmann, Max Planck Institute for Infection Biology-Berlin
Translating Basic Research in Tuberculosis into Vaccine and Biomarker Development
9:20 - 9:40 AM Coffee Break
11:30 AM- 2:00 PM On Own for Lunch
2:00 - 4:00 PM Workshop 3: HIV
Peter D. Kwong, National Institutes of Health
Targeting the Receptor-Binding Sites on HIV-1 gp120
Short Talks to be Chosen from Abstracts,
4:00 - 4:30 PM Coffee Break
4:30 - 7:00 PM Combating Emerging Pathogens
Registered attendees for this meeting can view Abstracts for this session starting on 09/22/2008
Robert E.W. Hancock, University of British Columbia
Selectively Modulating Innate Immunity
Sarah Randolph, University of Oxford
Predicting Arrival, Establishment and Spread of Exotic Diseases
Stefan H.I. Kappe, Seattle Biomedical Research Institute
Malaria Vaccine in Mice
7:00 - 8:00 PM Social Hour w/ Lite Bites
8:00 - 11:00 PM Entertainment
Monday, October 27
Departure
      *=Session Chair     †=Speaker invited, not yet responded.



Keystone Symposia would like to thank the sponsor of this meeting for their generous support:

We gratefully acknowledge additional support for this conference from:



 



We gratefully acknowledge the companies that provide Keystone Symposia with additional meeting support, including marketing and advertising...

Click here to view these companies

This meeting will review the most recent developments in the molecular and cellular analysis of infectious disease processes, and how discoveries in this field can be translated into innovative tools (i.e. diagnostic assays, new drugs, vaccines and other therapeutics) for better surveillance and control. Emphasis will be on the neglected infectious and parasitic diseases that plague the developing world (with lessons taken from better studied organisms), and on issues such as drug resistance that are common themes, regardless of geographic and economic situations.